Skip to main content
FinSpry Logo
FinSpry
RLAY logo
RLAY
(NASDAQ)
Relay Therapeutics, Inc.
$19.11-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Relay Therapeutics (RLAY) Stock Price & Financial Analysis

Relay Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$18.31 - $19.28
52-Week High$21.27
52-Week Low$3.87
Open$18.78
Volume4.48M
Average Volume (3M)2.30M
Market Cap3.42B
Shares Outstanding179.85M
Price to Sales (P/S)320.72
Price to Book (P/B)5.33
EV/EBITDA-11.89
Revenue (TTM)10.68M
Net Income (TTM)-272.70M
Free Cash Flow (TTM)-213.38M
EPS (TTM)$-1.57
Profit Margin-2554.14%
Operating Margin-2776.61%
Return on Equity (ROE)-42.47%
Debt to Equity0.05
50-Day MA$19.37
200-Day MA$13.03
52-Week Change370.69%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Relay Therapeutics

What is the current stock price for RLAY?

As of the latest trading session, RLAY stock trades at $19.11. The 52-week range is $3.87–$21.27, with a day range of $18.31–$19.28.

What is the P/E ratio for RLAY?

The P/E ratio (Price-to-Earnings) for RLAY is shown in the Key Statistics section. This valuation metric helps compare Relay Therapeutics, Inc. to industry peers.

Does RLAY pay dividends?

Relay Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for RLAY?

Based on 2 analysts, the consensus for RLAY is Buy.

What is the market cap of RLAY?

Relay Therapeutics's market capitalization is $3.44B, classifying it as a mid-cap company. Relay Therapeutics operates in the Healthcare sector within the Biotechnology industry.